Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

17.66
Delayed Data
As of Aug 31
 +0.02 / +0.11%
Today’s Change
9.20
Today|||52-Week Range
20.63
-0.90%
Year-to-Date

Today’s Trading

Previous close17.64
Today’s open17.64
Day’s range17.31 - 18.15
Volume305,377
Average volume (3 months)388,120
Market cap$616.8M
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-5.29%
Earnings growth (next 5 years)+9.06%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...-0.75-3.69%
AMPHAmphastar Pharmaceut...-0.52-3.88%
NWBONorthwest Biotherape...-0.41-5.06%
OMEROmeros Corp-1.41-9.10%
Data as of 3:59pm ET, 08/31/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
CFO, Treasurer &
Head-Investor Relations
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

Partner Offers